PBI12 Healthcare Resource Utilization and Costs in Patients with Psoriasis Who Switched to Biologic or Phosphodiesterase 4 Inhibitor Therapies Due to Inadequate Response
Saved in:
| Published in | Value in health Vol. 24; p. S16 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Inc
01.06.2021
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1098-3015 1524-4733 |
| DOI | 10.1016/j.jval.2021.04.083 |
Cover
| Author | Grabner, M. Isenberg, K. Shan, M. Burge, R. Teng, C.C. Garrelts, A. Curtis, J.R. Ridenour, T. |
|---|---|
| Author_xml | – sequence: 1 givenname: J.R. surname: Curtis fullname: Curtis, J.R. organization: University of Alabama at Birmingham, Birmingham, AL, USA – sequence: 2 givenname: M. surname: Grabner fullname: Grabner, M. organization: HealthCore, Inc., Wilmington, DE, USA – sequence: 3 givenname: R. surname: Burge fullname: Burge, R. organization: Eli Lilly and Company, Indianapolis, USA; Division of Pharmaceutical Sciences, University of Cincinnati, Indianapolis, IN, USA – sequence: 4 givenname: C.C. surname: Teng fullname: Teng, C.C. organization: HealthCore, Inc., Wilmington, DE, USA – sequence: 5 givenname: M. surname: Shan fullname: Shan, M. organization: Eli Lilly and Company, Indianapolis, IN, USA – sequence: 6 givenname: A. surname: Garrelts fullname: Garrelts, A. organization: Eli Lilly and Company, Indianapolis, IN, USA – sequence: 7 givenname: T. surname: Ridenour fullname: Ridenour, T. organization: Eli Lilly and Company, Indianapolis, IN, USA – sequence: 8 givenname: K. surname: Isenberg fullname: Isenberg, K. organization: Anthem Inc., Indianapolis, IN, USA |
| BookMark | eNqFUdtu1DAUjFCRaAs_wJN_IOHYzmWDEBJdKF2pEqtexKN14pwQh2AvtrdV-SP-EqflqRL0yUdzNOMzM0fZgXWWsuw1h4IDr99MxXSDcyFA8ALKAlbyWXbIK1HmZSPlQZqhXeUSePUiOwphAoBaiuow-7092XDBzgjnOGr0xC4ouL3XxK6jmc0vjMZZhrZnaxdiYMaybcLIpvnWxJFtg_MGgwns6-jYZcL0SD2Ljp0YN7tvRjPn2XZ0YTe63lCI5DEQK9nGjqYzMW2vxoTt0o593NNC3Vjs6ece4_09O2cDvcyeDzgHevX3Pc6uTz9drc_y8y-fN-sP57lO7mVeNx01WmiUWIJuqnaFEoB3gyas26oDLuUAsuLYQM-5aEXV4qrvagIaUFbyOBMPutq7EDwNaufND_R3ioNawlaTWsJWS9gKSpXCTqR3DyRKl90Y8irolJGm3njSUfXO_J_-_hFdz8YajfN3uqMwpUJs8qy4CkKBulzaXMoUHCC5K5PA238LPPX7H4eItSI |
| ContentType | Journal Article |
| Copyright | 2021 |
| Copyright_xml | – notice: 2021 |
| DBID | 6I. AAFTH AAYXX CITATION |
| DOI | 10.1016/j.jval.2021.04.083 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1524-4733 |
| EndPage | S16 |
| ExternalDocumentID | 10_1016_j_jval_2021_04_083 S1098301521003004 1_s2_0_S1098301521003004 |
| GroupedDBID | --- --K --M .1- .3N .FO .GA .Y3 .~1 0R~ 10A 123 1OC 1P~ 1~. 29Q 31~ 36B 4.4 44B 457 4G. 51W 51X 52N 52P 52R 52S 52X 53G 5LA 5VS 66C 6PF 7-5 7PT 8-1 8P~ 8UM AAEDT AAEDW AAFJI AAFWJ AAIKJ AAKOC AALRI AAMMB AAOAW AAPFB AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABCQN ABDBF ABEML ABIVO ABJNI ABMAC ABMMH ABMZM ABWVN ABXDB ACDAQ ACGFS ACHQT ACIEU ACPRK ACRLP ACRPL ACUHS ACVFH ACXQS ADBBV ADCNI ADEZE ADFHU ADMUD ADNMO ADVLN AEBSH AEFGJ AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AEYQN AFBPY AFEBI AFJKZ AFPUW AFRHN AFTJW AFXIZ AFZJQ AGCQF AGHFR AGQPQ AGTHC AGUBO AGXDD AGYEJ AIDQK AIDYY AIEXJ AIGII AIIAU AIIUN AIKHN AITUG AJAOE AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AOMHK APXCP ASPBG AVARZ AVWKF AXJTR AXLSJ AZFZN BAWUL BFHJK BKOJK BLXMC BNPGV BY8 CAG CO8 COF CS3 DCZOG DIK DU5 EAD EAP EBS EFJIC EFKBS EJD EMB EMK EMOBN ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN GBLVA HF~ HVGLF HZI HZ~ IHE IXB KOM LH4 M41 MO0 N9A O-L O9- OAUVE OIG OK1 OVD P-8 P-9 P2P PC. PQQKQ PRBVW Q38 QB0 R2- ROL SDF SEL SES SPCBC SSB SSF SSH SSO SSZ SV3 T5K TEORI TUS W99 WIN WYUIH XG1 YFH Z5R ~G- 0SF 6I. AACTN AAFTH AAHHS ABVKL ACCFJ AEEZP AEQDE AFCTW AFKWA AIWBW AJBDE AJOXV AMFUW NCXOZ RIG SUPJJ AAIAV ABLVK ABYKQ AJBFU AKYCK EFLBG IXIXF LCYCR AAYXX ACLOT CITATION ~HD |
| ID | FETCH-LOGICAL-c2023-67be7c2ca3a40c7598a3001bfcea695b0133f0351a70d1129259a8db6e0efa353 |
| IEDL.DBID | IXB |
| ISSN | 1098-3015 |
| IngestDate | Wed Oct 01 05:01:12 EDT 2025 Fri Feb 23 02:40:40 EST 2024 Sun Feb 23 10:18:45 EST 2025 Tue Aug 26 19:56:19 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | http://www.elsevier.com/open-access/userlicense/1.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2023-67be7c2ca3a40c7598a3001bfcea695b0133f0351a70d1129259a8db6e0efa353 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1098301521003004 |
| ParticipantIDs | crossref_primary_10_1016_j_jval_2021_04_083 elsevier_sciencedirect_doi_10_1016_j_jval_2021_04_083 elsevier_clinicalkeyesjournals_1_s2_0_S1098301521003004 elsevier_clinicalkey_doi_10_1016_j_jval_2021_04_083 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2021 |
| PublicationDateYYYYMMDD | 2021-06-01 |
| PublicationDate_xml | – month: 06 year: 2021 text: June 2021 |
| PublicationDecade | 2020 |
| PublicationTitle | Value in health |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| SSID | ssj0006325 |
| Score | 2.3011827 |
| SourceID | crossref elsevier |
| SourceType | Index Database Publisher |
| StartPage | S16 |
| SubjectTerms | Internal Medicine |
| Title | PBI12 Healthcare Resource Utilization and Costs in Patients with Psoriasis Who Switched to Biologic or Phosphodiesterase 4 Inhibitor Therapies Due to Inadequate Response |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1098301521003004 https://www.clinicalkey.es/playcontent/1-s2.0-S1098301521003004 https://dx.doi.org/10.1016/j.jval.2021.04.083 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1524-4733 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006325 issn: 1098-3015 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier Freedom Collection customDbUrl: eissn: 1524-4733 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0006325 issn: 1098-3015 databaseCode: ACRLP dateStart: 19980501 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect Open Access Journals customDbUrl: eissn: 1524-4733 dateEnd: 20241004 omitProxy: true ssIdentifier: ssj0006325 issn: 1098-3015 databaseCode: IXB dateStart: 19980501 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1524-4733 dateEnd: 20241004 omitProxy: true ssIdentifier: ssj0006325 issn: 1098-3015 databaseCode: AIKHN dateStart: 19980501 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection 2013 customDbUrl: eissn: 1524-4733 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006325 issn: 1098-3015 databaseCode: .~1 dateStart: 19980501 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1524-4733 dateEnd: 20241004 omitProxy: true ssIdentifier: ssj0006325 issn: 1098-3015 databaseCode: DIK dateStart: 19980101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1524-4733 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006325 issn: 1098-3015 databaseCode: AKRWK dateStart: 19980501 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbGkBAvCAaIwlbdA9oLC3Xi_Gget46pBW2KtFX0zbIdR82EklKnD3vh_9l_yTlxOqZNIPEYxydb-c7ni33fHSEfJZU6ESz18jhPvTASwhMqiDwqAp2gg6wDadnI5xfxdB5-XUSLHTLpuTA2rNLZ_s6mt9batYzc1xytynJ06dN0jOqJ-4_V1DYnKAuTlsS3ONla45i1hVdtZ8_2dsSZLsbrGtHEf8TAb9Odjtnjm9MfG87ZS_LCeYpw3E3mFdnR1R55du7uwvfIYdZlnb45gqs7EpU5gkPI7vJR37wmt9nJzA9guo30gv7MHuZN-cMRMUFUOUxq0xgoK8i6dKsG7DktZKZGPTWlge_LGi6xDaHOoamhK2VZKqjXOGptVsvahiVaWrPREMKsWpYSjcbazRHfwelGW9FZJXL9c4O-rp2PDdTVb8j87MvVZOq5Cg2esmXXvThBpFWgBBMhVUmUjgUi4ctCaRGnkT1jZYW9qxQJza1nhz9bYpzLWFNdCBaxt2S3qiv9joAuVOpLLVPp52GcR9iNSaXjgooiRUdlQD710PBVl4iD9xFq19wCyS2QnIYcgRwQ1qPHe4opGkWO-8RfpZLHpLRx69pwn5uAU_5A9wYk2kreU99_jPj-P-U-kOf2qYtZ2ye7zXqjD9A7auSQPPn8yx-Sp8ezb9OLYbsYfgNgfRLg |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemTgJeEBsgyse4B7QXFjXfaR5HtylhaxVprdibZSeOmmlKSp0-7E_iv-SucToQE0i82j7Z8u98d7bvg7FP0pYqEl5sFWERW34ghCVyN7Bs4aoIDWTlSopGns7CZOF_vQlu9tikj4Uht0oj-zuZvpXWpmVkdnO0qqrRtWPHY2RP1D_EqZQTdN8PUCYP2P5pepnMdgI59La1V2m8RQQmdqZz87pFQPGa6DrbjKdj73H99IvOuXjBnhtjEU679RywPVUfsidT8x1-yI6zLvH0_QnMH-Ko9AkcQ_aQkvr-JfuRfUkdF5Kdsxf0z_awaKs7E4sJoi5g0uhWQ1VD1mVc1UBPtZDpBllVVxq-LRu4xjZEu4C2ga6aZZVDs8ZZG71aNuSZSJHNWoEPab2sJMqNtVkj9sHZRhFpWotCfd-guUvrIV9d9YotLs7nk8QyRRqsnCqvW2GEYOduLjzh23kUxGOBYDiyzJUI44CeWb2SvitFZBdk3OF9S4wLGSpblcILvNdsUDe1esNAlXnsSCVj6RR-WAQ4zJO5CktblDHaKkP2uYeGr7pcHLx3UrvlBCQnILntcwRyyLwePd5HmaJc5Kgq_koVPUaltDnamjtcu9zmf7DfkAU7yt84-B8zvv1Puo_saTKfXvGrdHb5jj2jns6F7T0btOuN-oDGUiuPzGH4CSMYFIM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PBI12+Healthcare+Resource+Utilization+and+Costs+in+Patients+with+Psoriasis+Who+Switched+to+Biologic+or+Phosphodiesterase+4+Inhibitor+Therapies+Due+to+Inadequate+Response&rft.jtitle=Value+in+health&rft.au=Curtis%2C+J.R.&rft.au=Grabner%2C+M.&rft.au=Burge%2C+R.&rft.au=Teng%2C+C.C.&rft.date=2021-06-01&rft.pub=Elsevier+Inc&rft.issn=1098-3015&rft.volume=24&rft.spage=S16&rft.epage=S16&rft_id=info:doi/10.1016%2Fj.jval.2021.04.083&rft.externalDocID=S1098301521003004 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10983015%2FS1098301521X00137%2Fcov150h.gif |